2m 2m 2m 2m 2m 2m 2m
ELEDON PHARMA (ELDN)
NASDAQ
$2.79+$0.005 (+0.18%)
Price as of Sep 11, 2026 7:30 PM EDT- $225.9MMarket Cap
- 14.88%1-Year Change
- BiotechnologyIndustry
ELEDON PHARMA (ELDN)
$2.79+$0.005 (+0.18%)
ELDN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.78 | ||
Change | $0.00 (0.00%) | ||
Open | $2.82 | ||
High | $2.86 | ||
Low | $2.75 | ||
Previous Close | $2.78 | ||
Volume | 638,398 | ||
30-Day Average Volume | 970,808 | ||
1-Week Change | -7.95% | ||
1-Month Change | -25.87% | ||
1-Year Change | 14.88% | ||
3-Year Change | 110.61% | ||
5-Year Change | -63.75% | ||
Fundamentals | |||
Shares Outstanding | 81.3M | ||
Total Assets | $126.1M | ||
Market Cap | $225.9M | ||
Enterprise Value | $219.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$31.6M | ||
Free Cash Flow | -$22.7M | ||
EBIT | -$31.6M | ||
EBITDA | -$31.6M | ||
Net Working Capital | $81.3M | ||
EPS | -$0.27 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 7 | ||
P/E | -10 | ||
PEG | -1 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 18 | ||
Last Split Date | 10/05/2020 | ||
Earnings & Revenue